Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 222-222-9 | CAS number: 3390-61-2
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2000-03-30 to 2000-05-08
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 000
- Report date:
- 2000
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- An LLNA study was not performed because there is an existing reliable study for skin sensitisation using the Guinea Pig Maximisation test method. Furthermore, the LLNA test method is not considered to be suitable for substances that contain silicon. Please refer to the attached document for further details.
Test material
- Reference substance name:
- 1,3,3,5-tetramethyl-1,1,5,5-tetraphenyltrisiloxane
- EC Number:
- 223-620-5
- EC Name:
- 1,3,3,5-tetramethyl-1,1,5,5-tetraphenyltrisiloxane
- Cas Number:
- 3982-82-9
- Molecular formula:
- C28H32O2Si3
- IUPAC Name:
- 1,3,3,5-Tetramethyl-1,1,5,5-tetraphenyltrisiloxane
- Test material form:
- other: liquid
Constituent 1
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- Dunkin-Hartley
- Sex:
- male
- Details on test animals and environmental conditions:
- TEST ANIMALS
- Source: Not stated
- Age at study initiation: 5-8 weeks
- Weight at study initiation: 445-518 g
- Housing: Animals were housed in groups of five in suspended metal cages with wire mesh floors.
- Diet (e.g. ad libitum): Ad libitum
- Water (e.g. ad libitum): Ad libitum
- Acclimation period: 12 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 17.5 to 22.5
- Humidity (%): 31-52
- Air changes (per hr): 15
- Photoperiod (hrs dark / hrs light): 12/12
Study design: in vivo (non-LLNA)
Induction
- Route:
- intradermal
- Vehicle:
- other: Alembicol D
- Concentration / amount:
- 25 and 50 % (v/v) in Alembicol D
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: Alembicol D
- Concentration / amount:
- 25 and 50 % (v/v) in Alembicol D
- No. of animals per dose:
- Forty male guinea-pigs
- Details on study design:
- RANGE FINDING TESTS: The animals for the preliminary investigations w ere clipped and shaved the day prior to dosing and the animals for the topical irritancy investigations were re-shaved on the day of dosing. The procedure employed for these investigations were as follows: Intradermal injections - A range of concentrations of the test substance in Alembicol D were injected intradermally (0.I-ml/site) into the clipped left flank of two guinea pigs (per level tested) using a 1 ml plastic syringe and 26 G needle. The resulting dermal responses w ere assessed approximately 24, 48 and 72 hours later.
Topical application - Patches of Whatman No. 3 paper (20 mm x 20 mm) were saturated (volume approximately 0.2ml) with a range of concentrations of the test substance in Alembicol D and applied to the clipped and shaved flanks of each of four guinea-pigs. The patches w ere covered by a strip of "Blenderm" and firmly secured by "Elastoplast" wound round the trunk and fixed with 'sleek impervious plastic adhesive tape. The dressings were removed after an exposure period of approximately 24 hours and the reaction sites were assessed for erythema and oedema. Further examination of the sites was carried out approximately 24 and 48 hours after removal of the dressings.
Based on the results of the preliminary investigations the following concentrations of compound were selected:
Induction intradermal injection - l% vlv in Alembicol D. This was the highest concentation that caused slight irritation but did not adversely affect the animals.
lnduction topical application - as supplied. The test material applied topically as supplied by the Sponsor produced mild to moderate irritation but did not adversely affect the animals.
Topical challenge - 50 and 25% vlv in Alembicol D. From preliminary investigations 50 v/v in Alembicol D was the highest concentration not giving rise to irritating effects
MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: Two (intradermal injection and topical application)
-Test groups: FCA, TS in FCA (50:50 mixture), TS in Alembicol D
- Exposure period: Topical application left for 48 hours, 1 week after intradermal injections.
- Control group: Treated similarly to test animals with the exception that the test substance was omitted. Since there was no vehicle used, the negative control animals received a dry patch. Positive controls received 10% v/v hexyl cinnamic aldehyde (in Alembicol D for the injections) instead of the test substance.
- Site: Scapular region
- Concentrations: Unchanged test substance
B. CHALLENGE EXPOSURE:
- No. of exposures: One
- Day(s) of challenge: Two weeks after the topical induction application.
- Exposure period: Patches were sealed for 24 hours.
- Test groups: 0.2 ml TS in 50% v/v Alembicol D (anterior site), TS in 25% v/v Alembicol D (middle site), Alembicol D only (posterior site).
- Control group: Positive control: HCA in 50% v/v Alembicol and Alembicol only.
- Site: Left flank
- Evaluation (hr after challenge): Observations for clinical effects were conducted on days 1, 7 and 21 after challenge. Challenge sites were evaluated 24 and 48 hours after removal of patches. - Challenge controls:
- Negative controls: 0.2 ml of 50 % test material v/v in Alembicol D was applied to the anterior site, 25 % test material v/v in Alembicol D was applied to the middle site and Alembicol D to the posterior site.
Positive controls: Undiluted HCA was applied to the anterior site, 50 % v/v HCA in Alembicol D to the middle site and the vehicle Alembicol D to the posterior site. - Positive control substance(s):
- yes
- Remarks:
- hexyl cinnamic aldehyde
Results and discussion
- Positive control results:
- Intradermal injections: Slight to well defined erythema was observed in positive control animals following topical application with neat hexyl cinnamic aldehyde.
Challenge: All five positive control animals produced evidence of skin sensitisation.
In vivo (non-LLNA)
Resultsopen allclose all
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 25 %, 50 % v/v test material in Alembicol D, and Alembicol D alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 25 %, 50 % v/v test material in Alembicol D, and Alembicol D alone
- No. with + reactions:
- 0
- Total no. in group:
- 10
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 25 and 50% v/v in Alembicol D
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 25 and 50% v/v in Alembicol D
- No. with + reactions:
- 0
- Total no. in group:
- 20
- Remarks on result:
- no indication of skin sensitisation
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- HCA undiluted, 50 % v/v HCA in Alembicol D, and Alembicol D alone
- No. with + reactions:
- 4
- Total no. in group:
- 5
- Remarks on result:
- positive indication of skin sensitisation
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- HCA undiluted, 50 % v/v HCA in Alembicol D, and Alembicol D alone
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Remarks on result:
- positive indication of skin sensitisation
Applicant's summary and conclusion
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- In the skin sensitisation study, conducted according to OECD 406, and in compliance with GLP, the test material, 1,3,3,5-tetramethyl-1,1,5,5-tetraphenyltrisiloxane, was reported to be not sensitising to the skin of any of the test animals.
- Executive summary:
Based on the results of a preliminary study and in compliance with the guideline, an intradermal injection of Dow Corning 704 Diffusion Pump Fluid and 1% v/v in Alembicol D, followed by a topical application of Dow Corning 704 Diffusion Pump Fluid (as supplied) and then a challenge application of Dow Corning 704 Diffusion Pump Fluid, 50 % and 25% v/v in Alembicol D, were administered to guinea-pigs to determine the skin sensitising potential of Dow Corning 704 Diffusion Pump Fluid. Twenty test and ten control guinea-pigs were used in the main study, and five vehicle control and five positive control animals were used in the positive control study. In this study Dow Corning 704 Diffusion Pump Fluid did not produce evidence of skin sensitisation in any of the test animals. All animals in the positive control group produced evidence of skin sensitisation following treatment with hexyl cinnamic aldehyde.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
